Advertisement

Retinal oximetry and fractal analysis of capillary maps in sickle cell disease patients and matched healthy volunteers

  • W. A. J. BirkhoffEmail author
  • L. van Manen
  • J. Dijkstra
  • M. L. De Kam
  • J. C. van Meurs
  • A. F. Cohen
Open Access
Retinal Disorders
  • 247 Downloads

Abstract

Purpose

Fractal analysis can be used to quantitatively analyze the retinal microvasculature and might be a suitable method to quantify retinal capillary changes in sickle cell disease (SCD) patients. Retinal oximetry measurements might function as a proxy for the pathophysiology of cerebrovascular diseases. Moreover, hypoxia has an important role in the pathophysiology of diabetic and other retinopathies. However, little is known about the oximetry around the macula in SCD patients. With this study, we explored the feasibility to perform these quantified measurements in SCD patients.

Methods

Retinal microvascular and oximetry measurements were performed in eight SCD patients and eight healthy matched controls. Oximetry pictures and non-invasive capillary perfusion maps (nCPM) were obtained by the retinal function imager. Measurements were conducted twice on two different study days. Measured variables included monofractal dimension (Dbox), relative saturation, deoxygenated hemoglobin (deoxyHb), and oxygenated hemoglobin (oxyHb) concentration.

Results

No statistically significant differences in vessel density were found in the different annular zones (large vessels, p = 0.66; small vessels, p = 0.66) and anatomical quadrants (large vessels, p = 0.74; small vessels, p = 0.72). Furthermore, no significant between-group differences were found in the other different anatomical quadrants and annular zones around the fovea for relative saturation levels and deoxygenated Hb. However, the oxyHb levels were significantly lower in SCD patients, compared with those in matched controls in the temporal quadrants (p = 0.04; p = 0.02) and the superior nasal quadrant (p = 0.05).

Conclusions

Our study demonstrated the feasibility of multispectral imaging to measure retinal changes in oxygenation in both SCD patients and matched volunteers. The results suggest that in SCD patients before any structural microvascular changes in the central retina are present, functional abnormalities can be observed with abnormal oximetry measurements.

Keywords

Sickle cell disease Retina analysis Microvessels Image processing Computer-assisted 

Introduction

Sickle cell disease (SCD) is the most common inherited blood disorder in Europe and worldwide [1, 2]. Because of increasing immigration rates from Northern and sub-Saharan regions of Africa, SCD should be acknowledged as a major public health issue worldwide [3]. SCD is characterized by structural defects of the hemoglobin molecule, leading to acute or chronic anemia and vaso-occlusive crisis (VOC), which can lead to hospitalization and severe organ damage. Several organs might be affected including the kidneys, lungs, cerebrovascular damage, bones, and the retina [4]. In general, SCD is an inherited disease which may manifest itself already at early childhood. Due to chronicity of the disorder, patients may have intermittent live long symptoms and progressive organ failure due to multiple crises and insufficient oxygen perfusion.

Although SCD mostly manifests peripherally in the retina [5], structural and functional abnormalities in the retinal vasculature around the macula have been observed. [6, 7] Insights in these retinal microvascular changes allows for optimal diagnosis and treatment of SCD patients. The retina is known for its high demand for oxygen and might therefore function as a proxy for the pathophysiology of cerebrovascular diseases in general, but also for SCD.

Retinal oximetry is a non-invasive imaging technique wherein fundus photography is combined with the use of multispectral filters to determine oxygen saturation in the retinal blood vessels [8]. As abnormal retinal saturation plays an important role in the pathophysiology of retinopathies in several conditions [9], retinal oximetry imaging has been applied in several patient groups over the past decades [10, 11]. Information about the retinal microvasculature can be obtained through the analysis of non-invasive capillary perfusion maps (nCPM) by means of fractal analysis. Fractal analysis provides a global index that quantifies the geometric complexity of the retinal vascular network, summarizing the entire branching pattern, and may be a more sensitive indicator of early microvascular disease compared with overt retinopathy signs [12]. This method has been applied in patients with Diabetes Mellitus [13], Multiple Sclerosis [14], and high myopia [15].

Until now, knowledge about oximetry in retinal tissue around the macula in SCD patients is scarce. Oximetry images and nCPM can be obtained by the retinal function imager (RFI). Previous studies performed with the RFI were only able to perform a qualitative analysis of the oximetry status of the retina [10], whereas quantitative analysis can be more informative about the retinal status. The current study was the first to quantify retinal oximetry measurements obtained by the RFI in SCD patients and matched controls. With this study, we aimed to qualify new RFI-derived quantitative measures of retinal dysfunction in SCD.

Material and methods

Study population

Details about the study population, study design, outcome measures, and assessments were extensively described in the study protocol by Birkhoff et al. [7] In brief, retinal measurements were performed in SCD patients (self-reported) (n = 8) aged 18–65 years and healthy controls matched for age, ethnicity, gender, and body mass index (n = 8 for capillary maps imaging and n = 9 for oximetry measurements). SCD patients were recruited through advertisements in local papers or by referral from their treating specialist.

Study design

This was an observational study conducted at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands. RFI was conducted twice on two study days separated by 1 week. The study protocol was approved by the ethics committee of Leiden University and performed according to the Dutch law on medical research.

Retinal capillary maps imaging

Retinal microcirculation was quantified using the RFI 3005 (Optical Imaging, Rehovot, Israel). Measurements were performed as described in the study protocol [7]. In brief, one pupil was dilated using tropicamide. The subject remained seated quietly with the head in a headrest, which allowed for the collection of 10–15 series of eight retinal images in 20 degrees field of view over a period of 25 min. Of the eight images per subject, eight were used for fractal analysis of the nCPM. The images were initially edited and exported using Odian browse software (Optical Imaging, Rehovot, Israel). Subsequently, the best image series for each subject was manually selected based on the image quality (i.e., brightness and sharpness) and consequently analyzed.

Image processing

Fractal analysis of the nCPMs obtained by the RFI was performed with an automated Matlab (The Mathworks, Inc., Natick, MA, USA) script, which was described elsewhere [12]. In brief, acquired capillary maps were processed to separate microvessels from the original image. Subsequently, box-counting fractal analysis was performed on the processed images. Endpoints were defined as vessel density (Dbox) in different annular and quadrantal zones, which represents the counted small and large vessels at the capillary map. Figure 1 demonstrates the image processing of nCPMs.

Retinal oximetry

Retinal oximetry maps were acquired with use of the RFI by making series of eight retinal images in a field of view of 35 degrees, using a fast filter wheel with four different wavelengths, of which two oxygen-insensitive (548 nm and 586 nm) and two oxygen-sensitive (575 nm and 600 nm) wavelengths. The eight images were aligned and were acquired at 55–100 Hz. Each series contained two images of four different wavelengths. Dark reference images, captured by keeping the camera shutter closed, were used to correct for non-uniformity. Due to the lack of a reference standard, only relative oxygenation could be calculated. To normalize the images taken at the oxygen-sensitive wavelengths, we used the images taken at isosbestic points, i.e., a specific wavelength, at which the total absorbance of light of the oxygenated and deoxygenated Hb is equal (Fig. 2). The images taken at 600 nm were corrected with use of the images taken at 586 nm, thereby creating an image with deoxygenated Hb (deoxyrel = I600nm / I586nm). The images taken at 575 nm were normalized with use of the images taken at 548 nm, thereby creating an image with oxygenated Hb (oxyrel = I575nm / I548nm). Consequently, according to the modified Beer-Lambert law, a relative saturation map could be computed (SO2 rel = − log (oxyrel / oxyrel + deoxyrel) [16]. This relative saturation map was converted into a color-based map, to make interpretation of saturation easier (blue, low saturation; red, high saturation). For the analysis of the oximetry intensities, the best series were manualy chosen for each subject. We selected several regions of interest (ROIs), which were analyzed with use of MeVisLab, version 3.1 (MeVis Medical Solutions AG and Fraunhofer MEVIS, Germany). Circles were drawn showing four different diameters (10 mm, 25 mm, 50 mm, and 75 mm) around the macula. Four quadrants (superior nasal, inferior nasal, superior temporal, and inferior temporal) were defined. The side of each square, i.e., the size of the quadrants, was determined by taking the distance from the optic disk to the central part of the fovea. Outcomes indicative for the relative oxygen density were expressed per deoxygenated Hb and oxygenated Hb in arbitrary units (AU) and multiplied by 10,000 because the analysis in our software (i.e., calculations based on histograms) required integer values. Saturation was calculated from deoxygenated Hb and oxygenated Hb according to the modified Beer-Lambert law (Fig. 2).
Fig. 1

A non-invasive capillary perfusion map (nCPM) (a) processed into an acquired capillary map (b) for box-counting fractal analysis of vessel density

Statistical analysis

For repeatedly assessed endpoints (Dbox) of the capillary maps, contrasts between groups were estimated with a mixed model analysis of variance with fixed factors group (SCD patients and matched healthy subjects), day (day 1 and day 8), measurement (0 and 2 h), group by day, group by measurement and group by day by measurement, and subject, subject by day and subject by time as random factors. By using the same subject ID for the matched subjects, comparisons were pairwise. In both groups, the intra subject variability was calculated for Dbox, from the estimated variabilities within the statistical model.

For oxygenation determination, overall intensities (including minimum, maximum, mean, median, interquartile range (IQR) 25–75, peak intensity, and standard deviation) were calculated for each ROI. Each parameter was analyzed using a unpaired Student’s t test comparing SCD patients and matched controls; p values < 0.05 were considered statistically significant. For oxygenation maps, the minimal detectable effect size (MDES) was calculated, assuming a parallel comparison of two groups of eight subjects. All calculations were performed using SAS for windows V9.4 (SAS Institute, Inc., Cary, NC, USA).

Results

Study population

Subject characteristics are summarized in Table 1. All included subjects were female.
Table 1

Demographics

 

SCD patients (n = 8)

Matched controls (n = 8)

Age (years)

34 ± 7.5

31 ± 7.6

BMI kg/m2

25.4 ± 4.8

26.4 ± 4.2

Male:female

0:8

0:8

Systolic blood pressure (mmHg)

109 ± 8

116 ± 18

Diastolic blood pressure (mmHg)

65 ± 6

73 ± 12

Demographics obtained during the first occasion for capillary maps measurements. Vital signs were acquired before any measurement had taken place, in both occasions

Of all SCD patients, six had homozygous SCD (HbSS) and one heterozygous SCD (HbSE). One subject was uncertain about the SCD subtype. Patients received diverse medicaments, including folic acid, hydroxycarbamide, vitamin D, deferasirox, deferiprone, and acetaminophen. One SCD patient was on hydroxyurea therapy.

Capillary maps

Figure 3 summarizes the results from the fractal dimension analysis in SCD patients and matched controls, which was performed in the different anatomical quadrants and annular zones around the fovea. We found no significant difference between the SCD patients and the matched controls group with respect to vessel density (Dbox) in large vessels (estimate of the difference, 0.0096; 95%CI − 0.0376, 0.0568; p = 0.66) and small vessels (estimate of the difference 0.0033; 95%CI − 0.0146, 0.0212; p = 0.69) in the different annular zones around the fovea. In addition, we found no significant between-group difference with respect to vessel density in the different anatomical quadrants of large vessels (estimate of the difference 0.0086; 95%CI − 0.0488, 0.0659; p = 0.74) and small vessels (estimate of the difference 0.0188; 95%CI − 0.1299, 0.0923; p = 0.72).
Fig. 2

Schematic overview of oximetry measurements. Schematic overview of oximetry measurements. (1) Images were taken using a fast filter wheel with four different wavelengths, of which two oxygen-insensitive (548 nm and 586 nm) and two oxygen-sensitive (575 nm and 600 nm) wavelengths. (2) The images from oxygen-sensitive wavelengths were normalized with images from isosbestic points, thereby creating (de)oxygenated images. (3) According to the modified Beer-Lambert law, a relative saturation map was computed, of which different regions where analyzed

Oximetry maps

We found no significant between-group difference in the different anatomical quadrants and annular zones around the fovea with respect to relative saturation levels and deoxygenated Hb. Oxygenated Hb levels were significantly lower in SCD patients compared with those in matched controls in the temporal quadrant 2 (effect size (ES) = 850.3; 95%CI 69.16, 1631; p = 0.04), temporal quadrant 3 (ES = 919.9; 95%CI 171.4, 1668; p = 0.02), and the superior nasal quadrant 1 (ES = 763.8; 95%CI 16.03, 1512; p = 0.05). Table 2 provides an overview of all retinal oximetry outcomes in different quadrants and annular zones.
Table 2

Oxygen density measures in different quadrants and annular zones

 

SCD patients (n = 8)

Matched controls (n = 9)

Effect size controls VS SCD patients

p value

Annular zone 10 mm around the fovea

Saturation

2212 (210)

2191 (330)

− 20.52 (95%CI: − 328.5; 287.4)

0.89

Deoxygenated Hb

4609 (400)

4738 (692.4)

128.6(95%CI − 503.9; 761.2)

0.67

Oxygenated Hb

18,670 (958)

19,380 (595)

710.1 (95%CI − 124.0; 1544)

0.09

Annular zone 25 mm around the fovea

Saturation

2170 (189)

2130 (317)

− 40.54(95%CI − 331.6; 250.5)

0.77

Deoxygenated Hb

4561 (362)

4749 (708)

188.3(95%CI − 444.3; 820.9)

0.53

Oxygenated Hb

18,872 (995)

19,575 (606)

702.8 (95%CI − 157.6; 1563)

0.10

Annular zone 50 mm around the fovea

Saturation

2170 (153)

2102 (292)

− 68.14 (95%CI − 330.0; 193.7)

0.59

Deoxygenated Hb

4579 (310)

4577 (609)

− 1.937(95%CI − 45.4; 541.6)

0.99

Oxygenated Hb

18,940 (933)

19,605 (658)

665.1(95%CI − 186.3; 1517)

0.12

Annular zone 75 mm around the fovea

Saturation

2213 (133)

2127 (284)

− 89.19(95%CI − 336.3; 164.0)

0.47

Deoxygenated Hb

4638 (292)

4610 (594)

− 27.63(95%CI − 555.0; 499.7)

0.91

Oxygenated Hb

18,773 (861)

19,493 (668)

719.7 (95%CI − 98.17; 1538)

0.08

Quadrant 1: nasal superior

Saturation

2381 (168)

2197 (280)

− 183.1 (95%CI; 440.5–74.24)

0.15

Deoxygenated Hb

5031 (450)

4791 (646)

− 240.2 (95%CI; 856.5–376.1)

0.42

Oxygenated Hb

18,729 (693)

19,493 (691)

763.8 (95%CI 16.03; 1512)

0.05

Quadrant 2: temporal superior

Saturation

2378 (179)

2273 (265)

− 104.8 (95%CI 355.9; 146.2)

0.39

Deoxygenated Hb

4946 (474)

4926 (601)

− 20.33 (95%CI − 615.0; 574.3)

0.94

Oxygenated Hb

18,464 (810)

19,314 (650)

850.3 (95%CI 69.16; 1631)

0.04

Quadrant 3: temporal inferior

Saturation

2317 (176)

2243 (217)

− 74.11 (95%CI − 290.8; 142.6)

0.48

Deoxygenated Hb

4722 (327)

4823 (417)

101.0 (95%CI − 311.1; 513.2)

0.61

Oxygenated Hb

18,313 (755)

19,233 (642)

919.9 (95%CI 171.4; 1668)

0.02

Quadrant 4: nasal inferior

Saturation

2278 (185)

2267 (293)

− 10.86 (95%CI − 283.4; 261.7)

0.93

Deoxygenated Hb

4720 (374)

4825 (610)

104.5 (95%CI − 459.9; 668.8)

0.70

Oxygenated Hb

18,517 (1242)

18,983 (708)

465.9 (95%CI − 586.2; 1518)

0.36

Data are expressed as the mean (SD); means represent relative oxygen density in arbitrary units (AU); significant p values are in italic

Variability and minimal detectable effect size

Intra subject variability was small for most capillary map measurements, with a coefficient of variation (CV) < 10%. Based upon a parallel comparison of the two groups of eight subjects, the calculated MDES for oximetry measurements in the retina were 173 AU for saturation maps; 198 AU for oxygenated Hb maps, and 530 AU for deoxygenated Hb maps.

Discussion

In this study, we explored the performance of the RFI to study retinal oximetry measurements and to quantify capillary maps in SCD patients and matched healthy controls. A significant difference was observed for oxygenated Hb maps in the peri-foveal quadrants. Oxygenated Hb levels were significantly lower in SCD patients compared with those in matched controls. We found no significant difference in vessel density, saturation, and deoxygenated Hb maps between SCD patients and matched controls in all anatomical quadrants and annular zones.

RFI is a validated methodology that was designed to directly and non-invasively image the capillary network of the retina in great detail. RFI has been able to measure functional microvascular abnormalities in different patient groups, including SCD patients [7]. Furthermore, several studies have demonstrated the validity of fractal analysis of nCPM in different patients groups as multiple sclerosis patients and subjects with high myopia [15, 17]. Our results, showing a low intra subject variability for most nCPM endpoints, support these findings.
Fig. 3

Vessel density expressed in Dbox values for all vessels (a), small vessels in different quadrantal zones (b), and annular zones (c) image processing of nCPMs

Although previous studies using optical coherence tomography-angiography (OCT-A) in SCD patients found anatomical differences in capillary structure [6, 18], we were not able to repeat these results. This might be due to the fact that the sickle cell patients included in this study were relative healthy with no observed sickle cell retinopathy. This is also supported by a previous study which reported a strong correlation between vessel density around the fovea and retinal thickness, thereby confirming that the eyes of the patients included in this study were relatively unaffected by SCD [6].

Also, the limited sample size compared with that in previous studies [6, 18] might be responsible for this observed difference. Although RFI measurements have been claimed to be equal and even more detailed compared with OCT-A [19], the results might also have been distinct due to the use of different methodologies (fractal analysis versus density analysis). Furthermore, the inclusion of more peri-foveal regions and choroidal OCT-A measurements might have also induced more contrast compared with that in our study. Nevertheless, this methodology was able to observe early retinal changes as expressed by differences in oxygenated Hb.

Our measurements did not show a significant difference between the SCD group and the matched controls with respect to saturation measurements. This might be explained by the fact that the measured differences in endogenous contrast are probably too small for accurate detection. However, we were able to observe a significant difference in oxygenated Hb in the temporal quadrants of sickle cell patients, which is the location where the disease usually primarily manifests [20]. It is unclear why the superior nasal quadrant also shows statistical difference. As expected, findings in the nasal quadrant however showed a smaller difference compared with the findings in the temporal area. The differences in oxygenation levels more peripheral from the macula might indicate early retinal damage. Furthermore, in our analysis, we found a low inter-subject variability, demonstrated by a low SD, which is in turn reflected by a low MDES. This demonstrates that in case of clinically relevant changes, they would have been observed.

The retina is one of the highest energy-demanding tissues in the body, even surpassing the brain for metabolism, which leads to a high oxygen consumption [21]. Although decreased retinal vessel autoregulation has been reported in SCD patients [22], SCD patients may compensate their lower Hb and subsequently oxygen-carrying capacity by vascular autoregulatory mechanisms, such as the dilation of the vessels. This is demonstrated by higher retinal blood flow, previously measured in SCD patients [7]. Other techniques have also demonstrated an increased microvascular flow in other organs, thought to be a compensatory mechanism for the anemia [23, 24]. The sickle cell patients in this study had an unimpaired microvasculature around the macula, as demonstrated by the nCPM measurements. Therefore, the autoregulatory capacity of the retinal vessels might be sufficient in these patients, which in turn could lead to normal saturation levels when compared with those in controls. This theory is also confirmed in other studies [25]. Interestingly, our study demonstrates that even before microvascular changes are observed, early retinal changes can already be seen by the reduced level of oxygenated hemoglobin. This is in line with findings from other studies in which differences in other organs such as cerebral oximetry have been reported. [26]

This is the first study to quantitatively analyze multispectral pictures obtained by the RFI, whereas previous studies had only qualitatively analyzed multispectral pictures [10]. In our current analysis, we did not compensate for differences in path length, i.e., absorption and scattering, by the four wavelengths. The expected difference is negligible as the wavelengths are relatively close to each other. In contrast to other research, we measured oximetry as an average in the retinal tissue, not in the individual vessels. This is due to the fact that the current resolution of the RFI does not allow for the reliable quantification in individual vessels using our analysis technology.

A possible limitation of our study is that only females were included; therefore, we cannot exclude gender effects. However, since all SCD patients were matched to control subjects, this does not affect our main conclusions. Although this was an exploratory study, the limited number of participants caused a wider confidence interval for most outcomes. However, due to the low variability and subsequently the low MDES, any clinically relevant contrast would have been picked up. Furthermore, our measurements were performed around the central macula, whereas in SCD, retinal abnormalities are usually primarily observed peri-foveal. In this study, nCPM measurements were performed around the macula, contrary to structural changes that are usually observed in peripheral areas in SCD. We cannot exclude that these patients have abnormalities outside the field of view, more temporal to the fovea. Furthermore, a common drawback of RFI, opposed to OCT-A, is that it only measures the retinal vasculature, not the choroidal vasculature. It should also be noted that the oximetry measurements were still relative, due to the lack of golden standards for retinal oximetry. Nevertheless, our study demonstrated that small peri-foveal abnormalities expressed as subtle changes in oxygenated Hb can already be picked up by this methodology.

In summary, our study demonstrated the feasibility of multispectral imaging to measure retinal changes in oxygenation in both SCD patients and matched volunteers and that even before a loss of vascular flow can be detected, a reduced level of oxygenated hemoglobin might affect retinal function. With the developed methodology, future studies could be performed in which retinal health is monitored by measuring changes in retinal oxygenation in diseases such as Central Retinal Venous Occlusions (CRVO), or retinal detachment.

Notes

Acknowledgments

We would like to thank Jaspert de Vries for his help in the acquisition of the RFI images.

Funding information

LM was funded by the European Union Horizon 2020 Program under grant agreement number 692470 (ASTONISH project) and Topconsortia for Knowledge and Innovation (TKI’s) from the Dutch Ministry of Economic Affairs.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Leiden University and performed according to the Dutch law on medical research and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study before any measurement took place.

References

  1. 1.
    Ojodu J, Hulihan MM, Pope SN, Grant AM (2014) Incidence of sickle cell trait—United States, 2010. MMWR Morb Mortal Wkly Rep 63(49):1155–1158PubMedPubMedCentralGoogle Scholar
  2. 2.
    Modell B, Darlison M (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 86:480–487CrossRefGoogle Scholar
  3. 3.
    Weatherall DJ (2010) The inherited diseases of hemoglobin are an emerging global health burden. Blood blood-2010-01-251348Google Scholar
  4. 4.
    Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. Lancet 376(9757):2018–2031CrossRefGoogle Scholar
  5. 5.
    Fadugbagbe A, Gurgel R, Mendonça C, Cipolotti R, Dos Santos A, Cuevas L (2010) Ocular manifestations of sickle cell disease. Ann Trop Paediatr 30(1):19–26CrossRefGoogle Scholar
  6. 6.
    Han IC, Tadarati M, Pacheco KD, Scott AW (2017) Evaluation of macular vascular abnormalities identified by optical coherence tomography angiography in sickle cell disease. Am J Ophthalmol 177:90–99CrossRefGoogle Scholar
  7. 7.
    Birkhoff W, de Vries J, Dent G, Verma A, Kerkhoffs JL, van Meurs AHF et al (2018) Retinal microcirculation imaging in sickle cell disease patients. Microvasc Res 116:1–5CrossRefGoogle Scholar
  8. 8.
    Beach J (2014) Pathway to retinal oximetry. Transl Vis Sci Technol 3(5):2CrossRefGoogle Scholar
  9. 9.
    Stefánsson E, Olafsdottir OB, Einarsdottir AB, Eliasdottir TS, Eysteinsson T, Vehmeijer W et al (2017) Retinal oximetry discovers novel biomarkers in retinal and brain diseases. Invest Ophthalmol Vis Sci 58(6):BIO227–BBIO33CrossRefGoogle Scholar
  10. 10.
    Jittpoonkuson T, Garcia PM, Landa G, Rosen RB (2009) Retinal blood-flow velocity and oximetry status monitoring in a central retinal vein occlusion patient. Retin Physician 6(3):50–52Google Scholar
  11. 11.
    Einarsdottir AB, Hardarson SH, Kristjansdottir JV, Bragason DT, Snaedal J, Stefánsson E (2016) Retinal oximetry imaging in Alzheimer’s disease. J Alzheimers Dis 49(1):79–83CrossRefGoogle Scholar
  12. 12.
    Jiang H, DeBuc DC, Rundek T, Lam BL, Wright CB, Shen M et al (2013) Automated segmentation and fractal analysis of high-resolution non-invasive capillary perfusion maps of the human retina. Microvasc Res 89:172–175CrossRefGoogle Scholar
  13. 13.
    Zahid S, Dolz-Marco R, Freund KB, Balaratnasingam C, Dansingani K, Gilani F et al (2016) Fractal dimensional analysis of optical coherence tomography angiography in eyes with diabetic retinopathy. Invest Ophthalmol Vis Sci 57(11):4940–4947CrossRefGoogle Scholar
  14. 14.
    Jiang H, Delgado S, Tan J, Liu C, Rammohan KW, DeBuc DC et al (2016) Impaired retinal microcirculation in multiple sclerosis. Mult Scler J 22(14):1812–1820CrossRefGoogle Scholar
  15. 15.
    Li M, Yang Y, Jiang H, Gregori G, Roisman L, Zheng F et al (2017) Retinal microvascular network and microcirculation assessments in high myopia. Am J Ophthalmol 174:56–67CrossRefGoogle Scholar
  16. 16.
    Lu G, Qin X, Wang D, Chen ZG, Fei B editors (2015) Estimation of tissue optical parameters with hyperspectral imaging and spectral unmixing. Medical imaging 2015: biomedical applications in molecular, structural, and functional imaging. International Society for Optics and PhotonicsGoogle Scholar
  17. 17.
    Jiang H, Delgado S, Liu C, Rammohan KW, DeBuc DC, Lam BL et al (2016) In vivo characterization of retinal microvascular network in multiple sclerosis. Ophthalmology. 123(2):437CrossRefGoogle Scholar
  18. 18.
    Han IC, Tadarati M, Scott AW (2015) Macular vascular abnormalities identified by optical coherence tomographic angiography in patients with sickle cell disease. JAMA Ophthalmol 133(11):1337–1340CrossRefGoogle Scholar
  19. 19.
    Wang L, Jiang H, Grinvald A, Jayadev C, Wang J (2018) A mini review of clinical and research applications of the retinal function imager. Curr Eye Res 43(3):273–288CrossRefGoogle Scholar
  20. 20.
    Stevens TS, Busse B, Lee C-B, Woolf MB, Galinos SO, Goldberg MF (1974) Sickling hemoglobinopathies: macular and perimacular vascular abnormalities. Arch Ophthalmol 92(6):455–463CrossRefGoogle Scholar
  21. 21.
    Wong-Riley M (2010) Energy metabolism of the visual system. Eye Brain 2:99CrossRefGoogle Scholar
  22. 22.
    van Meurs JC, Schwoerer J, Schwartz B, Mulder PG, Meiselmann HJ, Johnson CS (1992) Retinal vessel autoregulation in sickle cell patients. Graefes Arch Clin Exp Ophthalmol 230(5):442–445CrossRefGoogle Scholar
  23. 23.
    Shi PA, Manwani D, Olowokure O, Nandi V (2014) Serial assessment of laser Doppler flow during acute pain crises in sickle cell disease. Blood Cells Mol Dis 53(4):277–282CrossRefGoogle Scholar
  24. 24.
    Minniti CP, Delaney KM, Gorbach AM, Xu D, Lee CC, Malik N et al (2014) Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia. Am J Hematol 89(1):1–6CrossRefGoogle Scholar
  25. 25.
    Shahidi M, Felder AE, Tan O, Blair NP, Huang D (2018) Retinal oxygen delivery and metabolism in healthy and sickle cell retinopathy subjects. Invest Ophthalmol Vis Sci 59(5):1905–1909CrossRefGoogle Scholar
  26. 26.
    Nahavandi M, Tavakkoli F, Hasan S, Wyche M, Castro O (2004) Cerebral oximetry in patients with sickle cell disease. Eur J Clin Investig 34(2):143–148CrossRefGoogle Scholar

Copyright information

© The Author(s) 2019
corrected publication 2019

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  1. 1.Centre for Human Drug ResearchLeidenthe Netherlands
  2. 2.Leiden University Medical CenterLeidenthe Netherlands
  3. 3.Oogziekenhuis RotterdamRotterdamthe Netherlands
  4. 4.ErasmusMCRotterdamthe Netherlands

Personalised recommendations